| Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic … T Vos, RM Barber, B Bell, A Bertozzi-Villa, S Biryukov, I Bolliger, ... The lancet 386 (9995), 743-800, 2015 | 6051 | 2015 |
| Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of … GA Roth, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... The Lancet 392 (10159), 1736-1788, 2018 | 4995 | 2018 |
| Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of … II Abubakar, T Tillmann, A Banerjee Lancet 385 (9963), 117-171, 2015 | 4914 | 2015 |
| Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying … CJL Murray, RM Barber, KJ Foreman, AA Ozgoren, F Abd-Allah, SF Abera, ... The Lancet 386 (10009), 2145-2191, 2015 | 3907* | 2015 |
| Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic … GBD 2015 Risk Factors Collaborators Lancet (London, England) 388 (10053), 1659, 2016 | 3184 | 2016 |
| The global burden of cancer 2013 C Fitzmaurice, D Dicker, A Pain, H Hamavid, M Moradi-Lakeh, ... JAMA oncology 1 (4), 505-527, 2015 | 2463 | 2015 |
| Global, regional, and national levels and causes of maternal mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 NJ Kassebaum, A Bertozzi-Villa, MS Coggeshall, KA Shackelford, ... The Lancet 384 (9947), 980-1004, 2014 | 1745 | 2014 |
| Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 CJL Murray, KF Ortblad, C Guinovart, SS Lim, TM Wolock, DA Roberts, ... The Lancet 384 (9947), 1005-1070, 2014 | 1198 | 2014 |
| Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 NJ Kassebaum, RM Barber, ZA Bhutta, L Dandona, PW Gething, SI Hay, ... The Lancet 388 (10053), 1775-1812, 2016 | 1000 | 2016 |
| Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 H Wang, CA Liddell, MM Coates, MD Mooney, CE Levitz, AE Schumacher, ... The Lancet 384 (9947), 957-979, 2014 | 948 | 2014 |
| Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the … NJ Kassebaum, M Arora, RM Barber, ZA Bhutta, J Brown, A Carter, ... The Lancet 388 (10053), 1603-1658, 2016 | 880 | 2016 |
| Thresholds for the cost–effectiveness of interventions: alternative approaches E Marseille, B Larson, DS Kazi, JG Kahn, S Rosen Bulletin of the World Health Organization 93, 118-124, 2014 | 823 | 2014 |
| Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic … R Lozano, N Fullman, D Abate, SM Abay, C Abbafati, N Abbasi, ... The lancet 392 (10159), 2091-2138, 2018 | 391 | 2018 |
| Cost-effectiveness of PCSK9 inhibitor therapy in patients with heterozygous familial hypercholesterolemia or atherosclerotic cardiovascular disease DS Kazi, AE Moran, PG Coxson, J Penko, DA Ollendorf, SD Pearson, ... Jama 316 (7), 743-753, 2016 | 327 | 2016 |
| Reducing cardiovascular mortality through prevention and management of raised blood pressure AJ Adler, D Prabhakaran, P Bovet, DS Kazi, G Mancia, V Mungal-Singh, ... Glob Heart 10 (2), 111-122, 2015 | 154 | 2015 |
| Updated cost-effectiveness analysis of PCSK9 inhibitors based on the results of the FOURIER trial DS Kazi, J Penko, PG Coxson, AE Moran, DA Ollendorf, JA Tice, ... Jama 318 (8), 748-750, 2017 | 151 | 2017 |
| Repolarization and activation restitution near human pulmonary veins and atrial fibrillation initiation: a mechanism for the initiation of atrial fibrillation by premature beats SM Narayan, D Kazi, DE Krummen, WJ Rappel Journal of the American College of Cardiology 52 (15), 1222-1230, 2008 | 146 | 2008 |
| Multivessel coronary artery bypass grafting versus percutaneous coronary intervention in ESRD TI Chang, D Shilane, DS Kazi, ME Montez-Rath, MA Hlatky, ... Journal of the American Society of Nephrology 23 (12), 2042-2049, 2012 | 141 | 2012 |
| Beta-blocker therapy and cardiac events among patients with newly diagnosed coronary heart disease C Andersson, D Shilane, AS Go, TI Chang, D Kazi, MD Solomon, ... Journal of the American College of Cardiology 64 (3), 247-252, 2014 | 139 | 2014 |
| Global burden of disease cancer collaboration: The global burden of cancer 2013 C Fitzmaurice, D Dicker, A Pain, H Hamavid, M Moradi-Lakeh, ... JaMa oncol 1 (4), 505-527, 2015 | 134 | 2015 |
